Asthma
Conditions
Brief summary
This Retrospective cohort study with an overall objective of to perform a descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment patterns and outcome.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Minimum two claims with asthma diagnosis, 30 days apart, during the identification period * Minimum 12 months of baseline period * Age ≥ 18 years on the index date * Continuous enrolment during the baseline period and at least 180 days of follow-up period; enrolment will be defined based on at least one activity during each 90-day period from the index date
Exclusion criteria
• Diagnosis of COPD during the baseline period. Diagnosis of COPD will be defined as ≥1 medical claim with an ICD-10 diagnosis in any position
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Asthma Patients Number | 1 Year | Number of unique asthma patients in the database during December 2015 through November 2018(summarized annually).it will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered all-cause if the associated medical claim(s) has a diagnosis code in any position for any condition. |
| Asthma-related Cost | 1 Year | Total asthma-related cost reported in the databse during December 2015 through November 2018(summarized annually).It will will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered asthma-related if the associated medical claim(s) has ICD-10 diagnosis code for asthma as the principal diagnosis |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Asthma-related hopitalizations cost | 1 Year | Number of asthma related hopistalizations and cost reported in the database during December 2015 through Novemebr 2018(Summairzed annually) |
| Astma-related prescription pattern | 1 Year | Prescription pattern of asthma-related medication by drug class during December 2015 through November 2018 |
| Severity of Asthma per total number of patients | 1 Year | Number of patients classified as Mild, moderate and severe asthmatic patinets as per the international guidlines. |
Countries
United Arab Emirates
Outcome results
None listed